Overview
STE market data
Price History
STE price chart · 1M
- O
- 233.71
- H
- 236.12
- L
- 232.85
- C
- 232.85
- Vol
- 42,916.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $233.71
- Previous Close
- $236.79
- Day High
- $236.12
- Day Low
- $232.85
- 52 Week High
- $241.14
- 52 Week Low
- $198.11
- 7 Day Return
- -1.26%
- 30 Day Return
- +1.09%
- 90 Day Return
- +9.66%
- 1 Year Return
- +9.70%
- Daily Notional Volume
- $10M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- 29.22 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $7.93 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.92 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 1.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 13.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $195.14 – $269.44 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $22.9B · P/B 3.02 · P/S 3.85.
Company News
UBS Maintains Buy on Steris, Lowers Price Target to $270Benzinga · Aug 7, 2026, 11:30 PM
Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275Benzinga · Aug 7, 2026, 5:16 PM
Steris Q1 Sales $1.493B Miss $1.498B EstimateBenzinga · Aug 5, 2026, 8:33 PM
8-K filing — STERIS plc (STE)SEC EDGAR · Aug 5, 2026, 8:33 PM
Steris Affirms FY2027 GAAP EPS Guidance of $9.00-$9.20 vs $9.08 EstBenzinga · Aug 5, 2026, 8:32 PM
Steris Widens FY2027 Adj EPS Guidance from $11.10-$11.30 to $11.00-$11.30 vs $11.16 Est; Affirms FY2027 Sales Guidance of $6.352B-$6.411B vs $6.371B EstBenzinga · Aug 5, 2026, 8:32 PM
Steris Q1 Adj. EPS $2.59 Beats $2.50 EstimateBenzinga · Aug 5, 2026, 8:31 PM
STERIS Plans $600M Investment To Construct Formulated Chemistries Manufacturing And Distribution Center Of Excellence In North CarolinaBenzinga · Aug 5, 2026, 12:46 PM
STERIS Raises Quarterly Dividend From $0.63 To $0.69 Per ShareBenzinga · Jul 30, 2026, 8:30 PM
UBS Initiates Coverage On Steris with Buy Rating, Announces Price Target of $275Benzinga · Jul 28, 2026, 6:24 PM